Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ann Zhufang Koay"'
Autor:
Julien Lescar, Yee Hwa Wong, Hui Qi Ng, Jeffrey Hill, Ann Zhufang Koay, Peter C. Dedon, CongBao Kang, Wenhe Zhong, Qianhui Nah, Yan Li
Publikováno v:
Josephina Lee
Bacterial tRNA (guanine37-N1)-methyltransferase (TrmD) plays important roles in translation, making it an important target for the development of new antibacterial compounds. TrmD comprises two domains with the N-terminal domain binding to the S-aden
Autor:
Yan, Li, Wenhe, Zhong, Ann Zhufang, Koay, Hui Qi, Ng, Qianhui, Nah, Yee Hwa, Wong, Jeffrey, Hill, Julien, Lescar, Peter C, Dedon, CongBao, Kang
Publikováno v:
Biomolecular NMR assignments. 13(2)
Bacterial tRNA (guanine37-N
Autor:
Qianhui Nah, Wenhe Zhong, Yan Li, Jeffrey Hill, Hui Qi Ng, Siau Hoi Lim, Ann Zhufang Koay, Peter C. Dedon, CongBao Kang, Julien Lescar, Andreas Larsson, Xiaoying Koh-Stenta
Publikováno v:
Josephina Lee
Bacterial tRNA (guanine37-N1)-methyltransferase (TrmD) is an important antibacterial target due to its essential role in translation. TrmD has two domains connected with a flexible linker. The N-terminal domain (NTD) of TrmD contains the S-adenosyl-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::513fa150696eb9febd91062bddc23789
https://hdl.handle.net/10356/150609
https://hdl.handle.net/10356/150609
Autor:
Yan, Li, Wenhe, Zhong, Ann Zhufang, Koay, Hui Qi, Ng, Xiaoying, Koh-Stenta, Qianhui, Nah, Siau Hoi, Lim, Andreas, Larsson, Julien, Lescar, Jeffrey, Hill, Peter C, Dedon, CongBao, Kang
Publikováno v:
Biomolecular NMR assignments. 13(1)
Bacterial tRNA (guanine
Autor:
CongBao Kang, Anders Poulsen, Stefan N. Constantinescu, Andrew K. Shiau, David Jenkins, Meng Ling Choong, Ann Zhufang Koay, May Ann Lee, Anna Ngo, Christian Pecquet, Qiwei Huang, Yasmine Ould-Amer, Carmen C. Diaconu
Publikováno v:
Combinatorial chemistryhigh throughput screening. 19(10)
Background: Rather than a Janus Kinase 2 inhibitor (ruxolitinib), a specific thrombopoietin receptor (TpoR) inhibitor would be more specific for the treatment of myeloproliferative neoplasms due to TpoR mutations. Objective: A cell-based phenotypic a